Review Article
Mayank Gangwar*,Gopal Nath
Abstract
Recently, numerous pre-clinical and clinical studies have shown their significant phage therapy efficacy against many antibiotic resistant pathogens and proved to be one of the best alternatives to the antibiotics. Bacteriophages can also be used as biocontrol agents in agriculture and petroleum industries. However, only few researchers have focused to monitor the phage-mediated acute immune reactions during phage therapy. Besides, phage safety was evaluated by determining toxicity after acute and sub-chronic oral administration of low and high dose of bacteriophages in male and female rodents. Here, in this study, we had orally administered the bacteriophages against Klebsiella pneumonia XDR strain in low (1015 PFU) and high dose (1020 PFU) quantities to rats in acute (single dose) and chronic toxicity (daily dose for 28 days) model. No significant clinical sign was observed in all the experimental groups as well as in the control animals. Besides, no significant change in feed intake and body weight was observed throughout the study period. After 28 days of phage dosing, blood was collected for estimation of hematology, biochemistry, and cytokines assay. The data suggested no alterations in the haematological profile, clinical biochemical parameters, relative organ weights, and immune biomarkers. Also, the gross pathological examinations of all the major organs were found to be normal across the treatment groups.